Literature DB >> 12224368

Lytic therapy in central venous catheters for hemodialysis.

Holly Fadness McFarland1, Lesley Dinwiddie, Janice Ferrell, Sue Forloines-Lynn.   

Abstract

Over the past 2 decades the use of central venous catheters (CVCs) for hemodialysis has become commonplace. While these devices have provided much needed temporary access to the bloodstream, they often become thrombosed and require procedures to restore patency. This article examines the lytic enzymes that are currently available and focuses on the assessment and treatment of thrombosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12224368

Source DB:  PubMed          Journal:  Nephrol Nurs J        ISSN: 1526-744X            Impact factor:   0.959


  1 in total

1.  Diabetes decreases patency of tunneled catheters in hemodialysis patients after first effective thrombolysis with urokinase.

Authors:  Dominika Wójtowicz; Dominika Cholewa; Anna M Faba; Beata Domańska; Joanna Kokoszka; Konrad Kopacz; Rafał Ficek; Tomasz Irzyniec; Sylwia E Rotkegel; Jerzy Chudek
Journal:  Ren Fail       Date:  2018-11       Impact factor: 2.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.